Your browser doesn't support javascript.
loading
A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care.
Taverner, Sofia; Eng, Cindy; Watson, Rebecca; George, Siba; Edwards, Amanda; Williams, David M; Stephens, Jeffrey W.
Afiliación
  • Taverner S; Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL, UK. Electronic address: Taverner91@gmail.com.
  • Eng C; Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL, UK.
  • Watson R; Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL, UK.
  • George S; Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL, UK.
  • Edwards A; Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL, UK.
  • Williams DM; Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL, UK.
  • Stephens JW; Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL, UK; Diabetes Research Group, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK.
Diabetes Metab Syndr ; 16(12): 102658, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36371968
ABSTRACT
BACKGROUND AND

AIMS:

Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) are associated with diabetic ketoacidosis (DKA), however limited case series are published.

METHODS:

We evaluated the characteristics of patients admitted with SGLT-2i associated DKA.

RESULTS:

Over 4 months, 22 patients were identified; 45.5% of DKA was not associated with concurrent illness.

CONCLUSION:

DKA is not uncommonly associated with SGLT2i with no clear patient factors associated with severity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Metab Syndr Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Metab Syndr Año: 2022 Tipo del documento: Article